News
These 3 Stocks Are Using Buybacks to Signal Market Confidence
Several key stocks are making notable buyback announcements. Below, we examine the latest moves by Trade Desk, Thermo Fisher, and Tapestry—and what they reveal about each company's capital return
Medtronic's Q2 Earnings & Revenues Beat Estimates, Stock Climbs
Medtronic plc MDT reported second-quarter fiscal 2026 adjusted earnings per share (EPS) of $1.36, which rose 7.9% from the year-ago quarter’s figure and beat the Zacks Consensus Estimate by 3.82%.
Is Kroger (KR) a Buy as Wall Street Analysts Look Optimistic?
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts
Amer Sports, Inc. (AS) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
Amer Sports, Inc. (AS) reported $1.76 billion in revenue for the quarter ended September 2025, representing a year-over-year increase of 29.7%. EPS of $0.33 for the same period compares to $0.14 a
Wall Street Analysts See Teradyne (TER) as a Buy: Should You Invest?
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm
Wall Street Bulls Look Optimistic About Micron (MU): Should You Buy?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side)
Home Depot (HD) Reports Q3 Earnings: What Key Metrics Have to Say
Home Depot (HD) reported $41.35 billion in revenue for the quarter ended October 2025, representing a year-over-year increase of 2.8%. EPS of $3.74 for the same period compares to $3.78 a year ago.
Brokers Suggest Investing in Allstate (ALL): Read This Before Placing a Bet
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts
Energizer (ENR) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
Energizer Holdings (ENR) reported $832.8 million in revenue for the quarter ended September 2025, representing a year-over-year increase of 3.4%. EPS of $1.05 for the same period compares to $1.22 a
Medtronic (MDT) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
For the quarter ended October 2025, Medtronic (MDT) reported revenue of $8.96 billion, up 6.6% over the same period last year. EPS came in at $1.36, compared to $1.26 in the year-ago quarter.
The
Wall Street Analysts Think Carnival (CCL) Is a Good Investment: Is It?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side)
Veeva (VEEV) Is Considered a Good Investment by Brokers: Is That True?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side)
Is It Worth Investing in Alaska Air (ALK) Based on Wall Street's Bullish Views?
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm
Wall Street Analysts Think Workday (WDAY) Is a Good Investment: Is It?
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm
Here's What Key Metrics Tell Us About Canaan (CAN) Q3 Earnings
Canaan (CAN) reported $150.48 million in revenue for the quarter ended September 2025, representing a year-over-year increase of 104.4%. EPS of -$0.05 for the same period compares to -$0.27 a year
Is It Worth Investing in Bank of America (BAC) Based on Wall Street's Bullish Views?
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts
Wall Street Bulls Look Optimistic About Badger Meter (BMI): Should You Buy?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side)
MPLX LP (MPLX) Boasts Earnings & Price Momentum: Should You Buy?
Here at Zacks, we offer our members many different opportunities to take full advantage of the stock market, as well as how to invest in ways that lead to long-term success.
The Zacks Premium
New to Investing? This 1 Computer and Technology Stock Could Be the Perfect Starting Point
Here at Zacks, we offer our members many different opportunities to take full advantage of the stock market, as well as how to invest in ways that lead to long-term success.
The Zacks Premium
OKLO Q3 Miss Deepens Stock Slide - Is Sentiment Turning Now?
Last week, Oklo Inc. OKLO delivered another disappointing quarter, marking its third miss in the last four reporting periods, and forcing investors to re-evaluate whether the hype-driven rally still
Should You Continue to Hold Hologic Stock Post Q4 Earnings?
Hologic HOLX will soon draw an end to its publicly traded phase, following an $18.3 billion agreement with U.S. private equity giants Blackstone and TPG. The buyout price consists of $76 per share
ASML's Mistral AI Investment: Is It a Catalyst for Next Growth Phase?
ASML Holding’s ASML latest strategic investment of €1.3 billion in Mistral AI signifies that the company is taking steps to move beyond being a traditional semiconductor tool provider. Mistral AI is
Do Options Traders Know Something About CRH Stock We Don't?
Investors in CRH plc CRH need to pay close attention to the stock based on moves in the options market lately. That is because the Jan. 16, 2026 $60.00 Call had some of the highest implied
Progyny, Inc. (PGNY) Hit a 52 Week High, Can the Run Continue?
A strong stock as of late has been Progyny (PGNY). Shares have been marching higher, with the stock up 36.6% over the past month. The stock hit a new 52-week high of $27.25 in the previous session


